Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2007-09-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM070398APMID 17845019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Economic Costs of Diabetes in the U.S. in 2007

  2008cited by this paper
• Expect the unexpected or caveat for drug designers: multiple structure determinations using aldose reductase crystals treated under varying soaking and co-crystallisation conditions.

  2006cited by this paper
• New chelation therapies and emerging chelating drugs for the treatment of iron overload

  2006cited by this paper
• Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.

  2005cited by this paper
• Pirenoxine prevents oxidative effects of argon fluoride excimer laser irradiation in rabbit corneas: biochemical, histological and cytofluorimetric evaluations.

  2005cited by this paper
• Naphtho[1,2-d]isothiazole acetic acid derivatives as a novel class of selective aldose reductase inhibitors.

  2005cited by this paper
• Spirohydantoin derivatives of thiopyrano[2,3-b]pyridin-4(4H)-one as potent in vitro and in vivo aldose reductase inhibitors.

  2005cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• A central role for inflammation in the pathogenesis of diabetic retinopathy

  2004cited by this paper
• Efficient activation of zinc: Application of the Blaise reaction to an expedient synthesis of a statin intermediate

  2004cited by this paper
• Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.

  2003cited by this paper
• The pharmacology of diabetic complications.

  2003cited by this paper
• Economic costs of diabetes in the US in 2002.

  2003cited by this paper
• Aldose reductase inhibitors from the nature.

  2003cited by this paper
• Genetic analysis of aldose reductase in diabetic complications.

  2003cited by this paper
• Molecular motors

  2003cited by this paper
• MELDRUM′S ACID IN ORGANIC SYNTHESIS. 2. A GENERAL AND VERSATILE SYNTHESIS OF β‐KETO ESTERS

  2002cited by this paper
• Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity.

  2002cited by this paper
• Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin‐induced diabetic rat tissues

  2001cited by this paper
• Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

  2001cited by this paper
• Global and societal implications of the diabetes epidemic

  2001cited by this paper
• A role for mitogen‐activated protein kinases in the etiology of diabetic neuropathy

  2001cited by this paper
• [1,2,4]Triazino[4,3-a]benzimidazole acetic acid derivatives: a new class of selective aldose reductase inhibitors.

  2001cited by this paper
• Ab initio study of flavonoids

  2000cited by this paper
• 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.

  1999cited by this paper
• A Pyrazole to Furan Rearrangement. Thermolysis of 5-Azido-4-formylpyrazoles.

  1999cited by this paper
• The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

  1999cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.

  1998cited by this paper
• Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities.

  1998cited by this paper
• Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.

  1998cited by this paper
• Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections

  1998cited by this paper
• A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil.

  1997cited by this paper
• Studies on the inhibitor‐binding site of porcine aldehyde reductase: Crystal structure of the holoenzyme‐inhibitor ternary complex

  1997cited by this paper
• Hyperglycemic cytosolic reductive stress 'pseudohypoxia': implications for diabetic retinopathy.

  1997cited by this paper
• Oxidized aldose reductase: in vivo factor not in vitro artifact.

  1996cited by this paper
• Specifically Targeted Modification of Human Aldose Reductase by Physiological Disulfides*

  1996cited by this paper
• A second generation force field for the simulation of proteins

  1995cited by this paper
• Harmonicity and anharmonicity in protein dynamics: A normal mode analysis and principal component analysis

  1995cited by this paper
• Human aldose reductase: pK of tyrosine 48 reveals the preferred ionization state for catalysis and inhibition.

  1995cited by this paper
• Preventing Non-Insulin-Dependent Diabetes

  1995cited by this paper
• Aldose reductase inhibitors and their potential for the treatment of diabetic complications.

  1994cited by this paper
• Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme.

  1994cited by this paper
• Hyperglycemic Pseudohypoxia and Diabetic Complications

  1993cited by this paper
• Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Ponalrestat: a potent and specific inhibitor of aldose reductase.

  1990cited by this paper
• A superfamily of NADPH-dependent reductases in eukaryotes and prokaryotes.

  1989cited by this paper
• Vitamin E as an in Vitro and in Vivo Antioxidant a

  1989cited by this paper
• The role of aldose reductase in the development of diabetic complications

  1988cited by this paper
• Strategic approaches to drug design. I. An integrated software framework for molecular modelling

  1987cited by this paper
• [Aldose reductase inhibitors].

  1986cited by this paper
• The crystal structures and hydrogen-bond properties of three 3-hydroxy-flavone derivatives

  1986cited by this paper
• A Broyden—Fletcher—Goldfarb—Shanno optimization procedure for molecular geometries

  1985cited by this paper
• Comparison of simple potential functions for simulating liquid water

  1983cited by this paper
• ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES

  1980cited by this paper
• Meldrum's acid in organic synthesis. 2. A general and versatile synthesis of .beta.-keto esters

  1978cited by this paper
• The Protein Data Bank: a computer-based archival file for macromolecular structures.

  1977cited by this paper
• Cleavage of protecting groups with boron tribromide

  1974cited by this paper
• The reaction of aminoheterocycles with reactive esters. I. Aminopyridines

  1968cited by this paper
• ISOLATION AND PROPERTIES OF LENS ALDOSE REDUCTASE.

  1965cited by this paper
• \the Protein Data Bank: a Computer-based Archival Le for Macromolecular Structures,"

  year unknowncited by this paper

• Design, synthesis, deep learning-guided prediction, and biological evaluation of novel pyridine-thiophene-based imine-benzalacetophenone hybrids as promising antimicrobial agent

  2025cites this paper
• g-C3N4-Based Heterogeneous Photocatalyzed Synthesis and Evaluation of Antitumor Activities of Fluoroalkylated 4H-Pyrido[1,2-a]pyrimidin-4-ones.

  2025cites this paper
• Novel Multifunctional Aldose Reductase Inhibitors Based on Quinoxalin‐2(1H)‐one Scaffold for Treatment of Diabetic Complications: Design, Synthesis, and Biological Evaluation

  2025cites this paper
• Toxic aldehydes in cooking vegetable oils: Generation, toxicity and disposal methods

  2025cites this paper
• Comprehensive Risdiplam Synthesis Overview: From Cross-Coupling Reliance to Complete Palladium Independence

  2025cites this paper
• Synthesis and biological studies of pyrimidine derivatives targeting metabolic enzymes

  2024cites this paper
• Ruthenium(II)-Catalyzed C-H/C-H (4+2) Annulation of 2-Aryl-N-heterocycles with Vinylene Carbonate.

  2024cites this paper
• A TEMPO-N3 Complex Enables the Electrochemical C-H Azidation of N-Heterocycles through the Cleavage of Alkoxyamines.

  2024cites this paper
• Synthesis, Antioxidant Activity, and Molecular Docking of Novel Paeoniflorin Derivatives

  2024cites this paper
• Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities.

  2024cites this paper
• CCC pincer Ru complex-catalyzed C–H vinylation/6π-E-cyclization of aldimines for constructing 4H-pyrido[1,2-a]pyrimidines

  2024cites this paper
• Microwave assisted synthesis, acetylcholinesterase inhibition and molecular docking studies of furo[2,3‐d]pyrido[1,2‐a]pyrimidin‐4‐one derivatives

  2024cites this paper
• Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry.

  2024cites this paper
• Determination of New 4-Aryl-pyrido[1,2-c]pyrimidine Derivatives, Potential Antidepressant Agents with a High Affinity to 5-Hydroxytryptamin 1A Receptor and Serotonin Transporter Protein Receptor, with Capillary Electrophoresis

  2023cites this paper
• Design and synthesis of novel quinazolin‐4(1H)‐one derivatives as potent and selective inhibitors targeting AKR1B1

  2023cites this paper
• Microwave-assisted straightforward synthesis of 2-substituted alicyclic fused pyrimidone

  2023cites this paper
• Efficient and metal Free synthesis of 2,3-disubstituted pyridopyrimidinones via ketenimine intermediates

  2023cites this paper
• Electro-Oxidative C3-Selenylation of Pyrido[1,2-a]pyrimidin-4-ones

  2023cites this paper
• Visible Light Assisted Direct C3-H Arylation of Pyrido[1,2-a]pyrimidin-4-ones and Thiazolo[3,2-a]pyrimidin-5-ones.

  2023cites this paper
• CuI-catalyzed synthesis of multisubstituted pyrido[1,2-a]pyrimidin-4-ones through tandem Ullmann-type C–N cross-coupling and intramolecular amidation reaction

  2023cites this paper
• Regioselective C(sp2)3−H thiocyanation of substituted 4H‐pyrido[1,2‐a]pyrimidin‐4‐ones and its derivatizations

  2023cites this paper
• Supporting Electrolyte-Free Electrochemical Oxidative C-H Sulfonylation and Thiocyanation of Fused Pyrimidin-4-ones in an All-Green Electrolytic System.

  2023cites this paper
• Electrochemical Oxidative Selenation of 4 H ‐Pyrido‐[1,2‐ a ]‐pyrimidin‐4‐ones with Diorganyldiselenides

  2023cites this paper
• N‐Chlorosuccinimide Mediated Regioselective Sulfenylation and Halogenation of 4 H ‐Pyrido[1,2‐ a ]pyrimidin‐4‐ones at Room Temperature

  2022cites this paper
• Nature-Inspired O-Benzyl Oxime-Based Derivatives as New Dual-Acting Agents Targeting Aldose Reductase and Oxidative Stress

  2022cites this paper
• Microwave-assisted annulation for the construction of pyrido-fused heterocycles and their application as photoluminescent chemosensors.

  2022cites this paper
• Identification of 9H‐purin‐6‐amine derivatives as novel aldose reductase inhibitors for the treatment of diabetic complications

  2022cites this paper
• Novel Hydroxychalcone-Based Dual Inhibitors of Aldose Reductase and α-Glucosidase as Potential Therapeutic Agents against Diabetes Mellitus and Its Complications.

  2022cites this paper
• Investigating structural aspects of Pyridopyrimidinone derivatives, an important precursor in medicinal chemistry

  2021cites this paper
• Identification of Novel SIRT1 Activators Endowed with Cardioprotective Profile.

  2021cites this paper
• Silver‐Catalyzed Direct Regioselective C3 Phosphonation of 4 H ‐pyrido[1,2‐ a ]pyrimidin‐4‐ones With H ‐phosphites

  2021cites this paper
• Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges

  2021cites this paper
• Catalyst-free one-pot synthesis of Novel 4H,5H-pyrano[2,3-d]pyrido[1,2-a]pyrimidin-5-one derivatives

  2021cites this paper
• Isatin derivatives as a new class of aldose reductase inhibitors with antioxidant activity

  2021cites this paper
• Recent advances in transition metal-catalyzed reactions of carbamoyl chlorides

  2021cites this paper
• [Bis(trifluoroacetoxy)iodo]benzene Mediated C‐3 Selenylation of Pyrido[1,2‐ a ]Pyrimidin‐4‐Ones Under Ambient Conditions

  2021cites this paper
• Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.

  2020cites this paper
• Comparative modeling and dynamic simulation of UDP-N-acetylmuramoyl-alanine ligase (MurC) from Mycobacterium tuberculosis through virtual screening and toxicity analysis.

  2020cites this paper
• Novel 3,4-dihydroquinolin-2(1H)-one derivatives as dual inhibitor targeting AKR1B1/ROS for treatment of diabetic complications: Design, synthesis and biological evaluation.

  2020cites this paper
• Anti-Diabetic Retinopathy Potential of Noni: The beneficial effect and possible mechanism

  2020cites this paper
• Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.

  2020cites this paper
• Polyhalonitrobutadienes as Versatile Building Blocks for the Biotargeted Synthesis of Substituted N-Heterocyclic Compounds †

  2020cites this paper
• HOMOLOGY MODEL, DOCKING ANALYSIS AND MOLECULAR DYNAMICS SIMULATION OF CANNABINOID CB2 RECEPTOR

  2020cites this paper
• Synthesis of Polysubstituted Pyridopyrimidines, Pyrimidines, and Pyrazoles Based on 1,1-Bis(1H-benzotriazol-1-yl)-and 1,1-Bis(3,5-dimethyl-1H-pyrazol-1-yl)-3,4,4-trichloro-2-nitrobuta-1,3-dienes

  2020cites this paper
• Molecular docking and dynamic simulation of UDP-N-acetylenolpyruvoylglucosamine reductase (MurB) obtained from Mycobacterium tuberculosis using in silico approach

  2020cites this paper
• Identification of quinoxalin-2(1H)-one derivatives as a novel class of multifunctional aldose reductase inhibitors.

  2019cites this paper
• Aldose reductase inhibitors: 2013-present

  2019cites this paper
• Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.

  2019cites this paper
• Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.

  2019cites this paper
• Three-Component Coupling of Aldehydes, 2-Aminopyridines, and Diazo Esters via Rhodium(III)-Catalyzed Imidoyl C-H Activation: Synthesis of Pyrido[1,2- a]pyrimidin-4-ones.

  2019cites this paper
• Computer-aided drug design based on comparative modeling, molecular docking and molecular dynamic simulation of Polyphosphate kinase (PPK) from Mycobacterium tuberculosis

  2019cites this paper
• Homology modeling and in silico toxicity assessment of potential inhibitors of cytidylate kinase from Mycobacterium tuberculosis

  2019cites this paper
• Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition.

  2019cites this paper
• Metal and Solvent-Free Synthesis of 2H-Pyrido[1,2-a]pyrimidin-2-ones Catalyzed by Elemental Sulfur

  2019cites this paper
• Synthesis of 2-Selenoxo-1,9a-Dihydro-2H-Pyrido [1,2-a]Pyrimidine Derivatives

  2019cites this paper
• A Metal‐free Approach for the Synthesis of Privileged 4 H ‐pyrido[1,2‐ a ]pyrimidin‐4‐one Derivatives over a Heterogeneous Catalyst

  2019cites this paper
• A 2,3-diphenylpyrido[1,2-a] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-α

  2019cites this paper
• Synthesis of pyridopyrimidinones by N-heterocyclic carbene palladium(II) supported on KCC-1 in aqueous solution

  2018cites this paper
• Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors.

  2018cites this paper
• Synthesis and biological evaluation of stilbene derivatives coupled to NO donors as potential antidiabetic agents

  2018cites this paper
• Manganese-Catalyzed Carbonylative Annulations for Redox-Neutral Late-Stage Diversification.

  2018cites this paper
• Copper-Catalyzed [4+2] Cycloaddition Using N -(2-Pyridyl)ketimines and Terminal Alkynes

  2018cites this paper
• Highly efficient one-pot synthesis of fused pyrimidones from 2-heteroaryl amines and Morita–Baylis–Hillman carbonates via intermolecular cyclocondensation

  2018cites this paper
• Molecular modelling and dynamic simulation of UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA) from Mycobacterium tuberculosis using in silico approach

  2018cites this paper
• Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.

  2017cites this paper
• Silver-catalyzed highly efficient synthesis of pyrido[1,2-a]pyrimidin-4-ones from 2-aminopyridines and alkynoates

  2017cites this paper
• Catalyst-Free Multicomponent Formation of Novel Acylpyrrole-Containing 6-Iminohexahydro-1H-pyrido[1,2-a]pyrimidine Derivatives

  2017cites this paper
• A nitrile-stabilized ammonium ylide as a masked C-C[double bond, length as m-dash]N synthon in heterocyclization with amidine-imine: 3-component assembly to fused pyrimidine scaffolds.

  2017cites this paper
• Cyclodextrin‐based nanosponges for the targeted delivery of the anti‐restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention

  2017cites this paper
• A Regioselective Synthesis of 6-Alkyl- and 6-Aryluracils by Cs2CO3- or K3PO4-Promoted Dimerization of 3-Alkyl- and 3-Aryl-2-Propynamides.

  2017cites this paper
• Hexafluoroisopropanol mediated benign synthesis of 2H-pyrido[1,2-a]pyrimidin-2-ones by using a domino protocol.

  2017cites this paper
• Hexafluoroisopropyl alcohol mediated synthesis of 2,3-dihydro-4H-pyrido[1,2-a]pyrimidin-4-ones

  2016cites this paper
• A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity.

  2016cites this paper
• Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents.

  2016cites this paper
• Multifunctional aldose reductase inhibitors based on 2H-benzothiazine 1,1-dioxide

  2016cites this paper
• Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα.

  2016cites this paper
• Simple and Efficient Synthesis of 2‐Oxo‐2H‐Pyrido[1,2‐a]Pyrimidin‐3(4H)‐Ylidene)Acetic Acid and Its Rearrangement in Presence of Acid Media

  2016cites this paper
• Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.

  2015cites this paper
• 3D-QSAR studies on flavone-8-acetic acid derivatives of aminopeptidase N inhibitors.

  2015cites this paper
• Crystal structure of 6-chloro-5-(2-chloroethyl)-3-(propan-2-ylidene)indolin-2-one

  2015cites this paper
• Synthesis and Biological Evaluation of Novel Gigantol Derivatives as Potential Agents in Prevention of Diabetic Cataract

  2015cites this paper
• Synthetic analogues of flavonoids with improved activity against platelet activation and aggregation as novel prototypes of food supplements.

  2015cites this paper
• Synthesis of 2-Arylpyridopyrimidinones, 6-Aryluracils, and Tri- and Tetrasubstituted Conjugated Alkenes via Pd-Catalyzed Enolic C-O Bond Activation-Arylation.

  2015cites this paper
• Novel Nitro Derivatives of Benzothiadiazine 1,1-Dioxide as Aldose Reductase Inhibitors

  2015cites this paper
• Pd-catalyzed carbonylative cycloamidation of ketoimines for the synthesis of pyrido[1,2-a]pyrimidin-4-ones.

  2015cites this paper
• Palladium-catalyzed direct alkenylation of 2-methyl-4H-pyrido[1,2-a]pyrimidin-4-ones using oxygen as the oxidant

  2015cites this paper
• Antioxidant action of 3-mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid, an efficient aldose reductase inhibitor, in a 1,1′-diphenyl-2-picrylhydrazyl assay and in the cellular system of isolated erythrocytes exposed to tert-butyl hydroperoxide

  2015cites this paper
• 3D-QSAR Studies, Molecular Dynamics Simulation and Free Energy Calculation of APN Inhibitors

  2015cites this paper
• Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity.

  2015cites this paper
• Copper-catalyzed oxidative annulation between 2-aminopyridine and arylidenemalononitrile leading to 4-oxo-pyrido[1,2- a ]pyrimidine-3-carbonitrile

  2015cites this paper
• Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.

  2015cites this paper
• Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug

  2015cites this paper
• Chiral resolution, determination of absolute configuration, and biological evaluation of (1,2-benzothiazin-4-yl)acetic acid enantiomers as aldose reductase inhibitors

  2015cites this paper
• Solvent‐Free Synthesis of 4H‐Pyrido[1,2‐a]pyrimidin‐4‐ones Catalyzed by BiCl3: A Green Route to a Privileged Backbone

  2015cites this paper
• Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.

  2015cites this paper
• Decreasing acidity in a series of aldose reductase inhibitors: 2-Fluoro-4-(1H-pyrrol-1-yl)phenol as a scaffold for improved membrane permeation.

  2014cites this paper
• Regioselective C3 alkenylation of 4 H-pyrido[1,2-a]pyrimidin-4-ones via palladium-catalyzed C-H activation.

  2014cites this paper
• Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors.

  2014cites this paper
• Multi-target drug design approaches for multifactorial diseases: from neurodegenerative to cardiovascular applications.

  2014cites this paper
• Copper-catalyzed asymmetric synthesis and comparative aldose reductase inhibition activity of (+)/(-)-1,2-benzothiazine-1,1-dioxide acetic acid derivatives.

  2014cites this paper